Gm6687, a predicted gene with expression in primary spermatocytes, seminiferous tubules, spermatids, and testis, plays a pivotal role in the intricate process of spermatogenesis. The gene's localization within these specific cellular compartments implies its involvement in critical stages of male germ cell development, suggesting its significance in shaping the cellular landscape of the testicular microenvironment. Spermatogenesis is a complex and highly regulated process involving the differentiation of spermatogonia into mature spermatozoa, and the expression of Gm6687 in primary spermatocytes and spermatids suggests its potential role in orchestrating key events during these developmental transitions. The gene's presence in the seminiferous tubules further underscores its involvement in the structural and functional aspects of the testis, likely contributing to the intricate interplay of signaling pathways governing spermatogenesis.
Inhibition of Gm6687 is approached indirectly through the modulation of specific signaling pathways associated with its expression sites. The intricate web of signaling cascades involves the phosphoinositide 3-kinase (PI3K)/Akt, mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK), transforming growth factor-beta (TGF-β), and other interconnected pathways. Inhibition of PI3K, for example, may disrupt the PI3K/Akt pathway, influencing Gm6687 expression in primary spermatocytes. Similarly, targeting mTOR with inhibitors like Rapamycin may impact Gm6687 indirectly, given the role of mTOR in regulating spermatocyte development. The modulation of MAPK pathways, including MEK1/2, p38 MAPK, and JNK, offers another avenue for potential Gm6687 inhibition, considering its expression in spermatids and seminiferous tubules. Additionally, TGF-β receptor inhibition can influence Gm6687 expression in seminiferous tubules, highlighting the complex interplay of signaling pathways in the regulation of this predicted gene. Understanding the nuanced interactions among these signaling pathways provides insights into the potential regulatory mechanisms governing Gm6687 expression during spermatogenesis. While direct inhibitors specific to Gm6687 remain unidentified, the chemical modulation of these interconnected pathways offers a sophisticated approach to indirectly influence the gene's expression and function. The complex regulatory network involving Gm6687 suggests a delicate orchestration of molecular events during spermatogenesis, and further exploration of these signaling pathways may unveil the intricate dynamics that govern male germ cell development in the testis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor disrupting the PI3K-Akt pathway. As Gm6687 is expressed in spermatocytes, this inhibition may indirectly affect its function by modulating the PI3K pathway critical in spermatogenesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K/Akt pathway inhibitor targeting PI3K. As Gm6687 is expressed in testis, inhibition of PI3K signaling may impact spermatogenesis and testicular functions through the downstream effects on gene regulation and cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor suppressing mTORC1. Since mTOR signaling is involved in spermatocyte development, rapamycin's inhibition may affect Gm6687 indirectly by modulating the mTOR pathway, influencing gene expression and cellular functions in testis. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $86.00 $153.00 $275.00 $452.00 | 3 | |
p38 MAPK inhibitor influencing MAPK signaling. Gm6687 expression in seminiferous tubules might be indirectly affected by SB203580, modulating p38 MAPK and subsequently impacting gene function through alterations in the cellular environment. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK1 inhibitor impacting the MAPK pathway. Gm6687 expression in primary spermatocytes could be indirectly influenced by PD98059, affecting the MAPK pathway and potentially altering gene function during spermatogenesis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor affecting the JNK pathway. Gm6687 expression in seminiferous tubules might be indirectly influenced by SP600125, modulating the JNK pathway and potentially altering gene function in the context of testicular cellular processes. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
Akt inhibitor targeting the PI3K/Akt pathway. As Gm6687 is expressed in spermatocytes, AZD5363's impact on the Akt pathway may indirectly alter the gene's function, potentially influencing spermatocyte development and related cellular processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-β receptor inhibitor disrupting TGF-β signaling. Gm6687 expression in seminiferous tubules might be indirectly affected by SB431542, modulating TGF-β signaling and potentially altering gene function in the context of testicular cellular processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Multi-kinase inhibitor impacting RAF/MEK/ERK signaling. Gm6687 expression in primary spermatocytes could be indirectly influenced by Sorafenib, affecting the RAF/MEK/ERK pathway and potentially altering gene function during spermatogenesis. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $30.00 $125.00 $445.00 | 45 | |
p38 MAPK inhibitor influencing MAPK signaling. Gm6687 expression in spermatids might be indirectly affected by SB202190, modulating p38 MAPK and potentially altering gene function through changes in the cellular environment during spermatogenesis. |